NCT01131676 · Interventional trial
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).
Overall registry status Completed
Phase 3
Conditions Diabetes Mellitus, Type 2
Delaware Valley sites
- 1245.25.10214 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory